Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of Anebulo Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: May 17, 2021
/s/ Aron R. English | |
| ARON R. ENGLISH | |
| 22NW FUND, LP | |||
| By: | 22NW Fund GP, LLC General Partner | ||
| By: | /s/ Aron R. English | ||
| Name: | Aron R. English | ||
| Title: | Manager | ||
| Pharma INVESTORS, LLC | |||
| By: | /s/ Aron R. English | ||
| Name: | Aron R. English | ||
| Title: | Owner | ||
